Introduction The diagnostic criteria of sexual dysfunctions (SDs) are paramount for the development of sexual medicine as reliable diagnoses are essential to guide treatment plans. Prior Diagnostic and Statistical Manual of Mental Disorders (DSM) classifications based definitions of SD mostly on expert opinions and included imprecise terms. The validity of diagnoses of SD has only recently been challanged, and efforts are made to make more operational definitions. Aim This paper aims to compare and contrast the recently released Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition (DSM-5) diagnostic criteria of SD with that of Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition Text Revision (DSM-IV-TR) and explains the rationale for making changes in the new DSM-5. It also aims to address some issues to be considered further for the future. Methods Online proposed American Psychiatric Association website DSM-5, the new released DSM-5, and DSM-IV-TR diagnostic criteria for SD were throughly inspected, and an extensive literature search was performed for comparative reasons. Main Outcome Measures Changes in diagnostic criteria of DSM-5 were detected, and DSM-IV-TR and DSM-5 diagnostic criteria for SD were compared and contrasted. Results Diagostic criteria were more operationalized, and explicit duration and frequency criteria were set up in DSM-5 for purposes of good clinical research. Classifications based on simple linear sexual response were abondoned, and diagnostic classifications were separetely made for males and females. Desire and arousal disorders in women were merged. Conclusions Drifting apart from linear sexual response cycle may be an advancement in establishing specific diagnostic criteria for different genders. However, it is still a question of debate whether there is enough evidence to lump sexual interest and arousal disorders in females. Making more precise definitions is important to differentiate disorders from other transient conditions. However, there is still room to improve our definitions and find a way to include gay and lesbian individuals. Further discussions and debates are expected to be continued in the future.
Ge liş ta ri hi/Re cei ved: 12.09.2011 Ka bul ta ri hi/Ac cep ted: 27.09.2011 © Nö rop si ki yat ri Ar şi vi Der gi si, Ga le nos Ya yı ne vi ta ra f›n dan ba s›l m›fl t›r. / © Arc hi ves of Neu ropsy chi atry, pub lis hed by Ga le nos Pub lis hing ÖZET Amaç: Çalışmada Türkçeye uyarlanan YAB-7 testinin , geçerlik, güvenirlik ve psikometrik özelliklerinin belirlenmesi amaçlandı.Yöntem: Çalışmaya YAB tanısı konulan 110 hasta 112 sağlıklı gönüllü katıldı. Başlangıç uygulamasının üç hafta sonrasında örneklemin belirli bir bölümüne YAB-7 testi yeniden uygulandı. Yapısal geçerlilik için ana bileşenler analizi, doğrulayıcı faktör analizi, ayırt edici özelliğin belirlenmesi için ROC analizi yapıldı. Değişik kesme değerlerinde pozitif öngörücü değer, negatif öngörücü değer, pozitif ve negatif olabilirlik oranı hesaplandı. Bulgular: YAB grubunda YAB-7 testi toplam puanları kontrol grubuna göre istatistiksel olarak anlamlı yüksek bulundu. YAB-7 testi tüm maddeleri arasında anlamlı ilişki, iç tutarlık ve aralıklı uygulamada iyi kararlılık gösterdiği görüldü. Yapısal geçerlilik için yapılan faktör analizinde YAB-7 testi faktör yapısının orijinal test ile benzer olduğu ve yapısal geçerliliğinin iyi olduğu saptandı. Doğrulayıcı faktör analizinde tek faktörlü yapıya iyi uyum gözlendi. YAB-7 testi için en kabul edilebilir kesme değeri 8 bulundu.Sonuç: YAB-7 Türkçe formunun klinik örneklemde orijinal forma benzer olarak yüksek geçerliğe, güvenilirliğe ve iyi psikometrik özelliklere sahip olduğu saptandı. YAB-7 Türkçe formunun yararlı bir tarama testi olarak değerlendirildi. (Nö rop si ki yat ri Ar fli vi 2013; 50: 53-58) Anah tar ke li me ler: Yaygın Anksiyete Bozukluğu-7 (YAB-7) testi, Türkçe uyarlama, geçerlik, güvenilirlik Çıkar çatışması: Yazarlar bu makale ile ilgili olarak herhangi bir çıkar çatışması bildirmemişlerdir. ABS TRACTObjective: Our objective was to identify the validity, reliability and psychometric features of the Turkish adaptation of the Generalized Anxiety Disorder-7 (GAD-7) scale. Method: Patients who were diagnosed with 110 GAD patients and 112 healthy control subjects were included in this study. Three weeks after the initial administration, a certain group of the sample was administered the GAD-7 scale again. The principal components analysis for structural validity and confirmatory factor analysis were performed. Receiver operating characteristics (ROC) curve analysis was performed to identify the distinguishing feature. Positive predictive value, negative predictive value, positive and negative likelihood ratios were calculated at different cut-off levels. Results: The total scores for the GAD-7 scale-Turkish version in the GAD group were found to be statistically significantly higher than those in the control group. A significant correlation was observed between all items of the GAD-7 scale -Turkish version that was found to have good internal consistency and intermittent administration. In the factor analysis performed for assessing the construct validity, the factor structure of the GAD-7 scale-Turki...
This study helps demonstrate the importance of psychosocial interventions in the treatment of schizophrenia. Recent advances in evidence-based psychosocial strategies can be implemented into routine clinical practice with additional clinical and social benefits.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.